Though seemingly obscure, 1-Propionyl-LSD represents the intriguing analog of this , a copyright drug garnering increasing attention among researchers . This structure entails the addition of the propionyl chain to the molecule, conceivably modifying its therapeutic profile. Insufficient information currently are available to definitively delineate